Breast Cancer Research Foundation

The Breast Cancer Research Foundation is the largest private funder of breast cancer research worldwide, headquartered in New York, NY. Operating through a streamlined and highly efficient grants program, BCRF identifies and supports the most promising scientific minds to advance critical research across all aspects of breast cancer care. The organization channels resources toward groundbreaking work in tumor biology, genetics, prevention, treatment, metastasis, and survivorship—enabling researchers to make discoveries and develop innovative approaches in record time. In 2025-2026, BCRF will distribute $74.75 million in annual grants to more than 260 scientists from leading universities and medical institutions across 16 countries. Beyond traditional grant funding, BCRF has established the Evelyn H. Lauder Founder's Fund, a multi-year international initiative representing the largest privately funded project exclusively focused on metastasis research in the world. Since its founding in 1993 by Evelyn H. Lauder, the organization has raised more than a billion dollars to fuel its mission. Recognized as one of the most financially efficient nonprofits in the country and the highest-rated breast cancer research organization in the nation, BCRF combines rigorous scientific standards with exceptional stewardship of donor resources. The foundation's commitment to accelerating research outcomes has transformed the landscape of breast cancer care, offering hope and improved outcomes to patients worldwide.